378 related articles for article (PubMed ID: 8174495)
1. Randomized comparative trial of imipenem/cilastatin versus aminoglycoside plus amoxycillin plus clindamycin in the treatment of severe intra- and post-operative infections.
Cakmakci M; Stern A; Schilling J; Christen D; Roggo A; Geroulanos S
Drugs Exp Clin Res; 1993; 19(5):223-7. PubMed ID: 8174495
[TBL] [Abstract][Full Text] [Related]
2. Imipenem/cilastatin versus aminoglycoside plus amoxicillin plus clindamycin in the treatment of serious postoperative infections.
Christen D; Buchmann P; Geroulanos S
Scand J Infect Dis Suppl; 1987; 52():11-4. PubMed ID: 3331039
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of two comparative antibiotic regimens in the treatment of serious intra-abdominal infections: results of a multicenter study.
Eckhauser FE; Knol JA; Raper SE; Mulholland MW; Helzerman P
Clin Ther; 1992; 14(1):97-109. PubMed ID: 1576632
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and tolerability of imipenem-cilastatin versus clindamycin+gentamicin for serious pelvic infections.
Larsen JW; Gabel-Hughes K; Kreter B
Clin Ther; 1992; 14(1):90-6. PubMed ID: 1576631
[TBL] [Abstract][Full Text] [Related]
5. Cost-analysis of imipenem-cilastatin monotherapy compared with clindamycin+aminoglycoside combination therapy for treatment of serious lower respiratory, intra-abdominal, gynecologic, and urinary tract infections.
Kreter B
Clin Ther; 1992; 14(1):110-21. PubMed ID: 1576620
[TBL] [Abstract][Full Text] [Related]
6. Postpartum endometritis: efficacy and tolerability of two antibiotic regimens.
Gonik B
Clin Ther; 1992; 14(1):83-9. PubMed ID: 1576630
[TBL] [Abstract][Full Text] [Related]
7. Imipenem/cilastatin versus amikacin plus piperacillin in the treatment of infections in neutropenic patients: a prospective, randomized multi-clinic study.
Norrby SR; Vandercam B; Louie T; Runde V; Norberg B; Anniko M; Andrien F; Baudrihaye M; Bow E; Burman LA
Scand J Infect Dis Suppl; 1987; 52():65-78. PubMed ID: 3331044
[TBL] [Abstract][Full Text] [Related]
8. Antimicrobial management of postoperative infections in abdominal surgery: single or combination regimen?
Geroulanos S; Stern A; Christen D; Buchmann P
Clin Ther; 1990; 12 Suppl B():34-42. PubMed ID: 2196121
[TBL] [Abstract][Full Text] [Related]
9. A randomized prospective study of cefepime plus metronidazole with imipenem-cilastatin in the treatment of intra-abdominal infections.
Garbino J; Villiger P; Caviezel A; Matulionyte R; Uckay I; Morel P; Lew D
Infection; 2007 Jun; 35(3):161-6. PubMed ID: 17565457
[TBL] [Abstract][Full Text] [Related]
10. The efficacy and safety of tigecycline for the treatment of complicated intra-abdominal infections: analysis of pooled clinical trial data.
Babinchak T; Ellis-Grosse E; Dartois N; Rose GM; Loh E; ;
Clin Infect Dis; 2005 Sep; 41 Suppl 5():S354-67. PubMed ID: 16080073
[TBL] [Abstract][Full Text] [Related]
11. Meropenem versus imipenem/cilastatin in the treatment of sepsis in Chinese patients.
Kuo BI; Fung CP; Liu CY
Zhonghua Yi Xue Za Zhi (Taipei); 2000 May; 63(5):361-7. PubMed ID: 10862445
[TBL] [Abstract][Full Text] [Related]
12. Results of the North American trial of piperacillin/tazobactam compared with clindamycin and gentamicin in the treatment of severe intra-abdominal infections. Investigators of the Piperacillin/Tazobactam Intra-abdominal Infection Study Group.
Eur J Surg Suppl; 1994; (573):61-6. PubMed ID: 7524798
[TBL] [Abstract][Full Text] [Related]
13. Comparison of imipenem/cilastatin with the combination of aztreonam and clindamycin in the treatment of intra-abdominal infections.
de Groot HG; Hustinx PA; Lampe AS; Oosterwijk WM
J Antimicrob Chemother; 1993 Sep; 32(3):491-500. PubMed ID: 8262872
[TBL] [Abstract][Full Text] [Related]
14. Randomized trial of imipenem-cilastatin versus gentamicin plus clindamycin in the treatment of polymicrobial infections.
Danziger LH; Creger RJ; Shwed JA; Stellato TA; Hau T
Pharmacotherapy; 1988; 8(6):315-8. PubMed ID: 3222164
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and tolerability of imipenem-cilastatin versus ceftazidime plus tobramycin as empiric therapy of presumed bacterial infection in neutropenic cancer patients.
Miller JA; Butler T; Beveridge RA; Kales AN; Binder RA; Smith LJ; Ueno WM; Milkovich G; Goldwater S; Marion A
Clin Ther; 1993; 15(3):486-99. PubMed ID: 8364941
[TBL] [Abstract][Full Text] [Related]
16. A comparison of imipenem/cilastatin with the combination of cefuroxime and metronidazole in the treatment of intra-abdominal infections.
Angerås MH; Darle N; Hamnström K; Ekelund M; Engström L; Takala J; Viste A; Holme JB
Scand J Infect Dis; 1996; 28(5):513-8. PubMed ID: 8953684
[TBL] [Abstract][Full Text] [Related]
17. Piperacillin/tazobactam vs imipenem/cilastatin in the treatment of nosocomial pneumonia--a double blind prospective multicentre study.
Schmitt DV; Leitner E; Welte T; Lode H
Infection; 2006 Jun; 34(3):127-34. PubMed ID: 16804655
[TBL] [Abstract][Full Text] [Related]
18. A randomized, controlled clinical trial on meropenem versus imipenem/cilastatin for the treatment of bacterial infections.
Hou F; Li J; Wu G; Zheng B; Chen Y; Gu J; Wang H; Huo L; Xue X; Jia C; Yin Y; Tian X; Ren S
Chin Med J (Engl); 2002 Dec; 115(12):1849-54. PubMed ID: 12622937
[TBL] [Abstract][Full Text] [Related]
19. Imipenem/cilastatin (1.5 g daily) versus meropenem (3.0 g daily) in patients with intra-abdominal infections: results of a prospective, randomized, multicentre trial.
Basoli A; Meli EZ; Mazzocchi P; Speranza V
Scand J Infect Dis; 1997; 29(5):503-8. PubMed ID: 9435041
[TBL] [Abstract][Full Text] [Related]
20. A randomized multicenter trial of piperacillin/tazobactam versus imipenem/cilastatin in the treatment of severe intra-abdominal infections. Swedish Study Group.
Eklund AE; Nord CE
J Antimicrob Chemother; 1993 Jan; 31 Suppl A():79-85. PubMed ID: 8383657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]